BC
DRTX

Broadfin Capital’s DURATA THERAPEUTICS INC COM STK (DE) DRTX Stock Holding History

Broadfin Capital’s Portfolio DRTX Stock Details DRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-188,706
Closed -$2.41M – 96
2013
Q4 		$2.41M Sell
188,706
-194,521
-51% -$2.04M 0.32% 50
2013
Q3 		$3.46M Hold
383,227
– – 0.61% 39
2013
Q2 		$2.76M Buy
+383,227
New +$2.81M 0.54% 38

Other funds holding DRTX

AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
CPV
Canaan Partners VII Westport, Connecticut $32.3M AUM 154.97% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Broadfin Capital's DRTX Position: Q1 2014 in Review

Broadfin Capital sold out of DURATA THERAPEUTICS INC COM STK (DE) (DRTX) in Q1 2014, closing a stake of 188,706 shares — an estimated $2.41M sold.

Broadfin Capital first reported a position in DRTX in Q2 2013 and held it in 3 quarters. The position peaked at $3.46M in Q3 2013. 59 funds tracked by Wall St. Rank hold DRTX as of Q1 2014.

  • Broadfin Capital reported no remaining DURATA THERAPEUTICS INC COM STK (DE) position as of Q1 2014 after selling out during the quarter.
  • Broadfin Capital sold 188,706 DURATA THERAPEUTICS INC COM STK (DE) shares in Q1 2014, an estimated $2.41M.
  • Broadfin Capital first reported a position in DURATA THERAPEUTICS INC COM STK (DE) in Q2 2013 and held it in 3 quarters.
  • Broadfin Capital's DURATA THERAPEUTICS INC COM STK (DE) position peaked at $3.46M in Q3 2013.
  • 59 funds tracked by Wall St. Rank held DURATA THERAPEUTICS INC COM STK (DE) as of Q1 2014.

Based on Broadfin Capital's 13F filing for Q1 2014, filed 15 May 2014.